SciELO - Scientific Electronic Library Online

 
vol.41 número4Trasplante hepático en la Unidad de Cuidados Intensivos: veinte años de experiencia en un centro de mediano ingreso en el PerúCondiciones laborales, calidad y percepciones sobre el ejercicio de la profesión: encuesta a médicos endoscopistas digestivos en Argentina índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista de Gastroenterología del Perú

versión impresa ISSN 1022-5129

Resumen

TARGARONA MODENA, Javier et al. There is a role for surgical resection in patients with oligometastatic pancreatic cancer. Rev. gastroenterol. Perú [online]. 2021, vol.41, n.4, pp.233-238. ISSN 1022-5129.  http://dx.doi.org/10.47892/rgp.2021.414.1097.

Objective:

The objective of this work is to retrospectively analyze the resection in patients with oligometastatic stage IV pancreatic adenocarcinoma, after first-line chemotherapy for metastatic pancreatic cancer, evaluating the survival of these cases.

Materials and methods:

Between January 2005 and December 2019, 5 patients diagnosed with oligometastatic pancreatic cancer undergoing first-line chemotherapy were retrospectively evaluated, after which resective surgery was performed.

Results:

The resective surgery performed in these patients were: three distal pancreatectomies with splenectomy, one duodenopancreatectomy and one total pancreatectomy. All received chemotherapy treatment; three patients received treatment with Folfurinox, one received 5-fluorouracil, and one received gemcitabine plus capecitabine. The patients received an average of 4 months of chemotherapy (3-6 months) and after this, resective surgery was scheduled. The average survival in these patients was 23 months (11 to 39 months), only one patient presented recurrence of the disease and died at 28 months, the remaining 4 are alive.

Conclusion:

Resective surgery in patients with stage IV pancreatic cancer can be done safely. This could be considered in selected patients with a good radiological and biochemical response after an adequate period of chemotherapy in whom there is no obvious distant disease.

Palabras clave : Pancreatic neoplasms; Drug therapy; Carcinoma, pancreatic ductal.

        · resumen en Español     · texto en Español     · Español ( pdf )